Antonios A Koutalos, Alexandros Koskiniotis, Christos Rountas, Efstathios Konstantinou, Sarah Georgiadou, Aggelos Stefos, Nikolaos K Gatselis, George N Dalekos, Konstantinos N Malizos
BACKGROUND & AIMS: During the pandemic, steroids use at various dosages and durations for the treatment of COVID-19 patients, especially in hospitalized patients, was a common and effective strategy. However, steroid administration is associated with osteonecrosis as an adverse event. The aim of the study was to examine the prevalence of skeleton osteonecrosis in COVID-19 patients treated with or without steroids. METHODS: Eighty randomly selected hospitalized COVID-19 patients were analyzed, of which 40 were managed with a published protocol including steroids and 40 did not receive steroids...
January 27, 2024: European Journal of Internal Medicine